Minolira

Last updated on RxList: 1/14/2021
Minolira Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

What Is Minolira?

Minolira (minocycline hydrochloride) extended-release tablets is a tetracycline-class drug indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. Minolira is available in generic form.

What Are Side Effects of Minolira?

Common side effects of Minolira include:

Dosage for Minolira

The recommended dosage of Minolira is approximately 1 mg/kg once daily for 12 weeks.

What Drugs, Substances, or Supplements Interact with Minolira?

Minolira may interact with anticoagulants, penicillin, antacids, iron preparations, and low dose oral contraceptives. Tell your doctor all medications and supplements you use.

Minolira During Pregnancy and Breastfeeding

Minolira is not recommended for use during pregnancy; it may harm a fetus. The use of drugs of the tetracycline class such as Minolira during tooth development may inhibit bone growth and cause permanent discoloration of teeth. Minolira may reduce the effects of oral contraceptives. Talk to your doctor about birth control options while taking Minolira. Minolira passes into breast milk but its effects on a nursing infant are unknown. Breastfeeding is not recommended while using Minolira.

Additional Information

Our Minolira (minocycline hydrochloride) Extended-Release Tablets Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

SLIDESHOW

Skin Health: 15 Tips for Clear Skin See Slideshow
Minolira Consumer Information

Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, fever, swollen glands, joint pain, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning in your eyes, skin pain, red or purple skin rash that spreads and causes blistering and peeling).

Seek medical treatment if you have a serious drug reaction that can affect many parts of your body. Symptoms may include: skin rash, fever, swollen glands, muscle aches, severe weakness, unusual bruising, or yellowing of your skin or eyes.

Call your doctor at once if you have:

  • bronchospasm (wheezing, chest tightness, trouble breathing);
  • a seizure;
  • kidney problems--little or no urination, swelling in your feet or ankles, feeling tired or short of breath;
  • low blood cell counts--fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath;
  • increased pressure inside the skull--severe headaches, ringing in your ears, dizziness, vision problems, pain behind your eyes; or
  • signs of liver or pancreas problems--loss of appetite, upper stomach pain (that may spread to your back), nausea or vomiting, loss of appetite, easy bruising or bleeding, dark urine, jaundice (yellowing of the skin or eyes).

Common side effects may include:

  • numbness, tingling, burning pain;
  • hair loss;
  • discoloration of you skin or nails.
  • dizziness, spinning sensation;
  • muscle or joint pain;
  • nausea, diarrhea, loss of appetite;
  • swollen tongue, cough, trouble swallowing;
  • rash, itching; or
  • headache.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Minolira (Minocycline Hydrochloride Extended-Release Tablets)

QUESTION

Acne is the result of an allergy. See Answer
Minolira Professional Information

SIDE EFFECTS

Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug, and may not reflect the rates observed in practice.

The following table summarizes selected adverse reactions reported in clinical trials at a rate of ≥1% for minocycline hydrochloride extended release tablets.

Table 2: Selected Treatment-Emergent Adverse Reactions in at least 1% of Clinical Trial

Adverse ReactionsMinocycline Hydrochloride Extended- Release Tablets
(1 mg/kg)
N = 674
(%)
Placebo
N = 364
(%)
At least one treatment emergency event379 (56)197 (54)
Headache152(23)83(23)
Fatigue62 (9)24 (7)
Dizziness59 (9)17 (5)
Pruritus31 (5)16 (4)
Malaise26 (4)9 (3)
Mood alteration17 (3)9 (3)
Somnolence13 (2)3 (1)
Urticaria10 (2)1 (0)
Tinnitus10 (2)5 (1)
Arthralgia9 (1)2 (0)
Vertigo8 (1)3 (1)
Dry Mouth7 (1)5 (1)
Myalgia7 (1)4 (1)

Postmarketing Experience

Adverse reactions that have been reported with minocycline hydrochloride use in a variety of indications include:

Skin and hypersensitivity reactions: fixed drug eruptions, balanitis, erythema multiforme, Stevens-Johnson syndrome, anaphylactoid purpura, photosensitivity, pigmentation of skin and mucous membranes, hypersensitivity reactions, angioneurotic edema, anaphylaxis, DRESS syndrome [see WARNINGS AND PRECAUTIONS].

Autoimmune conditions: polyarthralgia, pericarditis, exacerbation of systemic lupus, pulmonary infiltrates with eosinophilia, transient lupuslike syndrome.

Central nervous system: pseudotumor cerebri, bulging fontanels in infants, decreased hearing.

Endocrine: brown-black microscopic thyroid discoloration, abnormal thyroid function.

Oncology: thyroid cancer.

Oral: glossitis, dysphagia, tooth discoloration.

Gastrointestinal: enterocolitis, pancreatitis, hepatitis, liver failure.

Genitourinary: Preliminary studies suggest that use of minocycline may have deleterious effects on human spermatogenesis [see Nonclinical Toxicoloty].

Renal: reversible acute renal failure.

Hematology: hemolytic anemia, thrombocytopenia, eosinophilia.

Read the entire FDA prescribing information for Minolira (Minocycline Hydrochloride Extended-Release Tablets)

© Minolira Patient Information is supplied by Cerner Multum, Inc. and Minolira Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors